At AstraZeneca, we pride ourselves on crafting a collaborative culture that champions knowledge-sharing, ambitious thinking and innovation – ultimately providing employees with the opportunity to work across teams, functions and even the globe.

Recognizing the importance of individualized flexibility, our ways of working allow employees to balance personal and work commitments while ensuring we continue to create a strong culture of collaboration and teamwork by engaging face-to-face in our offices 3 days a week. Our head office and BlueSky Hub in downtown Toronto are purposely designed with collaboration in mind, providing space where teams can come together to strategize, brainstorm and connect on key projects.

Our dedication to sustainability is also central to our culture and part of what makes AstraZeneca a great place to work. We know the health of people, the planet and our business are interconnected which is why we’re taking ambitious action to tackle some of the biggest challenges of our time, from climate change to access to healthcare and disease prevention.

The Safety Epidemiology team within AstraZeneca houses the global team of PhD-trained pharmacoepidemiologists dedicated to the planning and execution of post-authorisation safety studies, intended for submission to various health authorities (e.g., FDA, EMA, etc), being conducted to better understanding the benefit-risk profile for nearly 100 marketed or pipeline products. As the project leads on AstraZeneca’s post-authorisation safety studies (PASS), our specialised team of pharmacoepidemiologists are responsible for ensuring that the design, execution, analysis and reporting of these studies are conducted under the highest scientific standards and delivered in a timely manner.

In addition to post-authorisation safety studies, Safety Epidemiology is responsible for performing targeted and systematic literature reviews to support various pharmacovigilance activities to help evaluate potential safety signals, as well as performing rapid data analytics on large electronic healthcare data sourced from around the globe. More recently, Safety Epidemiology has been tasked with setting the epidemiological strategy for FDA clinical trial diversity plans and conducting diversity-focused pharmacoepidemiology studies in support of regulatory submissions, which help to ensure that AstraZeneca products are safe and effective across different race/ethnicity, age and gender categories.

Safety Epidemiology offers a dynamic, inclusive and supportive environment where epidemiologists with a passion for drug safety could thrive in their careers, being able to make a meaningful and tangible contribution to drug development, pharmacoepidemiology, and public health. If you’re a recent graduate of a PhD or post-doctorate programme in epidemiology, with an interest in drug safety and pursuing a career in the pharmaceutical industry, we welcome you to apply.

Essential Requirements

• Ph.D. in pharmacoepidemiology, epidemiology or related health science field and substantial hands-on experience in a research environment
• A strong interest in pursuing a career in pharmacoepidemiology and drug safety
• Able to apply advanced epidemiological theory and techniques to solve new and challenging problems
• Able to conduct targeted and/or systematic literature reviews on drug safety related topics in a timely manner
• Able to provide critical appraisal to study designs and published epidemiological studies
• Able to work effectively with internal & external collaborators, including collaborative groups and contract research organizations (CROs)

Desirable Requirements

• PhD dissertation in pharmacoepidemiology or epidemiology with a strong focus on medicines as the exposure of interest
• Hands-on experience in utilizing secondary data and primary data collection studies and knowledge of patient safety databases for use in generating real-world evidence (RWE)
• Understanding of drug safety and medical terminology and ability to summarize medical information drug safety experience in a clinical or post-marketing environment.
• Good therapeutic and disease area knowledge and knowledge of drug development and life cycle management
• Knowledge and experience with drug safety reporting and regulatory compliance and experience with international drug safety reporting/regulations, including PASS and RWE studies, Risk Management Plans and Signal Management
• Substantial knowledge and experience in epidemiological methods and research in drug development or in a closely related academic research area

Great People want to Work with us! Find out why:

• GTAA Top Employer Award for 11 years
• Top 100 Employers Award
• Canada’s Most Admired Corporate Culture
• Learn more about working with us in Canada
• View our YouTube channel

Are you interested in working at AZ, apply today!

AstraZeneca is an equal opportunity employer that is committed to diversity and inclusion and providing a workplace that is free from discrimination. AstraZeneca is committed to accommodating persons with disabilities. Such accommodation is available on request in respect of all aspects of the recruitment, assessment and selection process and may be requested by emailing AZCHumanResources@astrazeneca.com.

#LI-Hybrid